BNF

BNF

20 May . 3 min read.
bookmark_border


BNF ONLINE

https://bnf.nice.org.uk

 

BNF for CHILDREN ONLINE

https://bnfc.nice.org.uk

Therapeutic area Weighting
Cardiovascular system High
Nervous system High
Endocrine system High
Infection High
Genito-urinary tract system Medium
Gastro-intestinal system Medium
Respiratory system Medium
Immune system and malignant disease Medium
Blood and nutrition Medium
Musculoskeletal system Low
Eye Low
Ear, nose, and oropharynx Low
Skin Low
Vaccines Low
Anaesthesia Low

Ref: https://www.pharmacyregulation.org/53-registration-assessment-framework

BNF CHAPTERS: REVISION NOTES

Chapter 1 – GI

Chapter 2 – CVS

Chapter 3 – Respiratory

Chapter 4 – Nervous

Chapter 5 – Infection

Chapter 6 – Endocrine

Chapter 7 – Genito-urinary

Chapter 8 – Malignant disease

Chapter 9 – Blood and nutrition

Chapter 10 – Muskuloskeletal

Chapter 11 – Eye

Chapter 12 – Ear, Nose, and Oropharynx

Chapter 13 – Skin

Chapter 14 – Vaccines

Chapter 15 – Anaesthesia

Chapter 17 – Summaries

 

A list of some of the topics/subjects that are covered in the BNF:

  •   E numbers
  •   Latin abbreviations
  •   Abbreviations and symbols used in the BNF
  •   Drug treatment for medical emergencies in the community
  •   Resuscitation Council (UK) adult advanced life support algorithm
  •   Table showing mean values for weight, height and gender by age
  •   Approximate weight conversion chart
  •   Non-medical prescribing
  •   Nurse Prescribers’ Formulary
  •   Dental Practitioners’ Formulary
  •   Cautionary and advisory labels for dispensed medicines
  •   Wound management products and elasticated garments
  •   Borderline substances – ACBS
  •   Intravenous additives
  •   Drug interactions
  •   Drugs in pregnancy
  •   Drugs in breast-feeding
  •   Prescribing in renal impairment
  •   Prescribing in hepatic impairment
  •   Drugs and driving
  •   Reporting of suspected adverse drug reactions through the Yellow Card

 

Scheme

  •   MHRA/CHM advice
  •   Prescribing for children
  •   Palliative care prescribing
  •   Drug prescribing for the elderly
  •   Prescribing in dental practice
  •   Drugs and sport
  •   Treatment of poisoning e.g. paracetamol poisoning treatment graph
  •   Sugar-free oral liquid preparations
  •   Extemporaneous preparation
  •   Oral syringes
  •   EEA prescriptions
  •   Patient group direction (PGD)
  •   Emergency supply of medicines
  •   Prescription requirements for controlled drugs
  •   Classification of controlled drugs by schedule
  •   Low Na+ antacids
  •   Regimens for Helicobacter pylori eradication
  •   Prescribing for patients with a stoma
  •   Classification of anti-arrhythmic drugs
  •   Thresholds and targets for treatment of hypertension
  •   Indications and target INRs for warfarin
  •   Management of stable angina, NSTEMI and STEMI
  •   Management of acute and chronic asthma based on recommendations

from the British Thoracic Society and SIGN

  •   Use of inhaled therapies in COPD based on recommendations of NICE
  •   Anaphylaxis and angioedema treatment
  •   IM adrenaline (epinephrine) dose for the emergency treatment ofanaphylaxis
  •   Standard and high dose inhaled corticosteroids
  •   Treatment of croup
  •   Equivalent doses of benzodiazepines
  •   Equivalent doses of oral and depot antipsychotics
  •   Status epilepticus
  •   Notifiable diseases
  •   Summary of antibacterial therapy and prophylaxis
  •   Tuberculosis treatment
  •   Prophylaxis against malaria
  •   HbA1c equivalent values
  •   Drivers with diabetes
  •   Equivalent anti-inflammatory doses of corticosteroids
  •   HRT risk table
  •   Prescribing drugs for G6PD-deficient individuals
  •   Electrolyte concentrations – IV fluids
  •   Electrolyte content – gastrointestinal secretions
  •   Electrolyte concentrations – infusion fluids for parenteral feeding
  •   Drugs unsafe for use in patients with acute porphyrias
  •   Excipients in eye drops
  •   Suitable quantities of dermatological and corticosteroids preparations to be

prescribed for specific areas of the body

  •   Suitable quantities of parasiticidal preparations for treatment of head lice,scabies and crab lice
  •   Excipients in topical preparations that may be associated with sensitisation
  •  Immunisation schedule
  •  Surgery and long-term medication
  •  Iron content of different iron salts
  •  Phenylketonuria
  •  Conversion from oral morphine to transdermal fentanyl

Please note this list is not intended to be a complete list of all the topics/subjects covered in the BNF or BNFC.

x
We use cookies to ensure that we give you the best experience on our website. If you would like to change your preferences you may do so by following the instructions here. More info. That's fine